ZEAL logo

Zealand Pharma A/S (ZEAL) Accounts Payable

Annual Accounts Payable

$9.83 M
-$1.81 M-15.52%

December 31, 2021


Summary


Performance

ZEAL Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherZEALbalance sheetmetrics:

Quarterly Accounts Payable

$4.78 M
-$111.40 K-2.28%

September 1, 2022


Summary


Performance

ZEAL Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherZEALbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ZEAL Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-15.5%-44.2%
3 y3 years+96.5%+8.4%
5 y5 years+107.2%+16.5%

ZEAL Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat highat low-51.4%at low
5 y5-year-15.5%-12.9%-60.8%at low
alltimeall time-15.5%-93.1%-60.8%-72.3%

Zealand Pharma A/S Accounts Payable History

DateAnnualQuarterly
Sep 2022
-
$4.78 M(-2.3%)
Jun 2022
-
$4.89 M(-23.2%)
Mar 2022
-
$6.37 M(-35.2%)
Dec 2021
$9.83 M(-15.5%)
$9.83 M(+14.7%)
Sep 2021
-
$8.57 M(-29.8%)
Jun 2021
-
$12.20 M(+65.8%)
Mar 2021
-
$7.36 M(-36.8%)
Dec 2020
$11.63 M(+35.9%)
$11.63 M(+19.6%)
Sep 2020
-
$9.73 M(-4.6%)
Jun 2020
-
$10.20 M(+65.4%)
Mar 2020
-
$6.16 M(-28.0%)
Dec 2019
$8.56 M(+71.1%)
$8.56 M(+94.1%)
Sep 2019
-
$4.41 M(-35.1%)
Jun 2019
-
$6.79 M(+53.9%)
Mar 2019
-
$4.41 M(-11.8%)
Dec 2018
$5.00 M(+5.5%)
$5.00 M(+31.2%)
Sep 2018
-
$3.81 M(-17.0%)
Jun 2018
-
$4.60 M(+59.8%)
Mar 2018
-
$2.88 M(-39.3%)
Dec 2017
$4.74 M(+68.9%)
$4.74 M(+15.6%)
Sep 2017
-
$4.10 M(+15.0%)
Jun 2017
-
$3.57 M(+11.9%)
Mar 2017
-
$3.19 M(+13.7%)
Dec 2016
$2.81 M
$2.81 M(+29.2%)
Sep 2016
-
$2.17 M(-22.2%)
DateAnnualQuarterly
Jun 2016
-
$2.79 M(+29.1%)
Mar 2016
-
$2.16 M(-31.9%)
Dec 2015
$3.18 M(+5.2%)
$3.18 M(+39.7%)
Sep 2015
-
$2.27 M(-7.1%)
Jun 2015
-
$2.45 M(+0.2%)
Mar 2015
-
$2.44 M(-19.1%)
Dec 2014
$3.02 M(+21.9%)
$3.02 M(+89.7%)
Sep 2014
-
$1.59 M(-10.6%)
Jun 2014
-
$1.78 M(+16.9%)
Mar 2014
-
$1.52 M(-38.4%)
Dec 2013
$2.48 M(+42.1%)
$2.48 M(+86.0%)
Sep 2013
-
$1.33 M(-53.3%)
Jun 2013
-
$2.85 M(+115.6%)
Mar 2013
-
$1.32 M(-24.1%)
Dec 2012
$1.74 M(+16.4%)
$1.74 M(+21.4%)
Sep 2012
-
$1.44 M(+2.0%)
Jun 2012
-
$1.41 M(-25.1%)
Mar 2012
-
$1.88 M(+25.5%)
Dec 2011
$1.50 M(-21.3%)
$1.50 M(-12.7%)
Sep 2011
-
$1.72 M(+15.7%)
Jun 2011
-
$1.48 M(-4.0%)
Mar 2011
-
$1.54 M(-18.8%)
Dec 2010
$1.90 M(+181.5%)
$1.90 M
Dec 2009
$676.10 K(-52.2%)
-
Dec 2008
$1.41 M(+101.1%)
-
Dec 2007
$703.00 K
-

FAQ

  • What is Zealand Pharma A/S annual accounts payable?
  • What is the all time high annual accounts payable for Zealand Pharma A/S?
  • What is Zealand Pharma A/S annual accounts payable year-on-year change?
  • What is Zealand Pharma A/S quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Zealand Pharma A/S?
  • What is Zealand Pharma A/S quarterly accounts payable year-on-year change?

What is Zealand Pharma A/S annual accounts payable?

The current annual accounts payable of ZEAL is $9.83 M

What is the all time high annual accounts payable for Zealand Pharma A/S?

Zealand Pharma A/S all-time high annual accounts payable is $11.63 M

What is Zealand Pharma A/S annual accounts payable year-on-year change?

Over the past year, ZEAL annual accounts payable has changed by -$1.81 M (-15.52%)

What is Zealand Pharma A/S quarterly accounts payable?

The current quarterly accounts payable of ZEAL is $4.78 M

What is the all time high quarterly accounts payable for Zealand Pharma A/S?

Zealand Pharma A/S all-time high quarterly accounts payable is $12.20 M

What is Zealand Pharma A/S quarterly accounts payable year-on-year change?

Over the past year, ZEAL quarterly accounts payable has changed by -$3.79 M (-44.21%)